Tag: bioequivalence challenges
Complex Generic Drugs: Why FDA Approval Is Harder Than You Think
Complex generic drugs face steep FDA approval hurdles due to intricate formulations and delivery systems. Learn why bioequivalence is harder to prove for inhalers, injectables, and liposomes, and how GDUFA II aims to streamline the process.
